Hong Kong/China Insurance Report Interpretation
Morgan Stanley finds broad-based, high-quality growth across life and P&C insurers, supported by strong earnings, VNB growth, improving profitability and resilient capital metrics. The report remains constructive on execution but highlights slowing quarterly growth, tougher comparisons and channel-regulation adjustment.
Summary
Morgan Stanley finds broad-based, high-quality growth across life and P&C insurers, supported by strong earnings, VNB growth, improving profitability and resilient capital metrics. The report remains constructive on execution but highlights slowing quarterly growth, tougher comparisons and channel-regulation adjustment.
- All insurers recorded double-digit 1H earnings growth, aided by the equity rally.
- Life insurers delivered 11–34% VNB growth except PICC Life and Taiping, but only AIA China and CPIC achieved positive 2Q growth.
- China insurers' annualized operating ROE remained healthy at 14–21%, while regional insurers AIA and FWD improved.
- P&C profitability strengthened on manageable catastrophe losses and lower expense ratios.
- New bancassurance regulations and a high late-August sales base could weigh on near-term growth.
Report Interpretation
Overview
This industry wrap-up reviews 1H26 performance across Hong Kong and China insurers. Morgan Stanley concludes that results were strong and growth quality remained resilient, while attention should turn to tougher 3Q26 comparisons, sales momentum, bancassurance regulatory adjustment and 2027 sales preparation.
Core views
Morgan Stanley’s review of more than 40 peer-comparison charts finds that Hong Kong and China insurers produced strong 1H26 results across life and P&C. All insurers delivered double-digit earnings growth, supported by the equity-market rally. The report highlights wider disclosure of earnings measures that exclude short-term investment volatility as a constructive development. China insurers’ annualized operating ROE may decline slightly but remains healthy at 14–21%, while AIA and FWD increased their operating ROE. Interim dividends per share rose across all names. Investment and capital trends were broadly supportive but require monitoring. Insurers generally increased allocations to funds and FVOCI equities. Net investment yield declined by 0.1–0.4 percentage points across peers to 1.2–1.5%, while gross investment yield rose to 2.1–4.2% in 1H; Morgan Stanley identifies net yield as an important issue under new asset-liability-management rules. National-team holdings in insurers declined in 2Q but remained sizeable. The report also notes broad reductions in life insurers’ sensitivity of VNB and embedded value to a 50bp fall in investment returns. Life-insurance new-business trends were strong but less uniform on a quarterly basis. Most insurers delivered 11–34% 1H26 VNB growth, with PICC Life and Taiping at single-digit growth. Only AIA China and CPIC achieved positive 2Q growth, signaling a slowdown against a higher base. Channel drivers diverged: Ping An showed stronger bancassurance growth, whereas most peers relied more on agency. VNB margins rose for most insurers except Ping An and Taiping, and new-business CSM ranged from a 1.6x increase to a 22% decline. Morgan Stanley nevertheless points to continued 2–10% half-on-half CSM, net-asset and life embedded-value growth; higher persistency; positive operating variance; double-digit agent-productivity growth; healthy product mix; and lower rate sensitivity as evidence of underlying quality. P&C results improved through manageable catastrophe losses and lower expense ratios in both auto and non-auto lines. Most P&C players improved their combined ratios, while non-auto premium growth exceeded auto growth. Morgan Stanley cautions that 3Q catastrophe losses could create short-term pressure, although expense discipline and favorable regulation could continue to support industry profitability. Company briefings illustrate differentiated execution. AIA reported 10% 1H26 VNB growth in line with consensus and continued to see structural Hong Kong demand from mainland Chinese visitors; it added more than 25,000 MCV customers, bringing its in-force MCV book to about 550,000. FWD expects 2H Hong Kong margin and growth to remain broadly consistent with 1H, though margins should seasonally moderate in 2H; management expects 2026 NB CSM and VNB margins to improve versus 2025. Ping An expects its multi-channel strategy, enhanced services and AI enablement to support VNB growth over time, and has invested 5–8% of profits in AI around three- to five-year targets. Among mainland life insurers, China Life reduced its effective duration gap to below 1.3 years; guaranteed liability cost for new business fell 61bp in 2025 and another 39bp in 1H26 to 1.73%, while back-book guaranteed cost declined to 2.87–2.88%. CPIC was one of the few insurers with better 2Q than 1Q performance and sees channel-expansion opportunities across city tiers. Taiping reported robust earnings but weaker VNB and combined-ratio trends; catastrophe losses rose to about Rmb100mn in 1H26 and were expected at Rmb470mn for July–August, though management viewed the overall effect as controlled. ZhongAn reported earnings up 1.3x and a 95.5% combined ratio, with AI integrated across operations and token consumption exceeding 34trn in 1H26 versus 3trn in 2025. Looking forward, Morgan Stanley sees continued high-quality execution but stresses three near-term watchpoints: sales momentum following the late-August high base, bancassurance adaptation to strengthened regulation, and the start of 2027 sales preparation. Tough 3Q26 earnings and VNB comparisons could make reported growth more challenging even where underlying operational trends remain healthy.
Analysis framework
Morgan Stanley compares more than 40 peer charts and company results across earnings, operating ROE, VNB, margins, CSM, persistency, channels, investment yields, capital and solvency. It then supplements the peer analysis with management-briefing takeaways to assess the durability of growth and near-term risks.
Methodology notes
Use of operating earnings measures that deduct short-term investment volatility, alongside operating ROE, CSM, persistency and operating variance.
The report uses these measures to distinguish underlying insurance operating performance from short-term market-driven investment movements.
Comparison of VNB growth, channel mix, VNB margins, agent productivity and product mix.
Morgan Stanley assesses whether new-business growth comes from sales channels, productivity and margins rather than a single driver.
Comparison of net and gross investment yields and their movement across insurers.
The report treats investment-yield trends as central to insurers’ earnings and ALM outlook under the new rules.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- AIA Group Ltd (1299.HK)Regional life-insurance peer benefiting from Hong Kong MCV demand and diversified growth engines.
- Strengths
- 10% 1H26 VNB growth in line with consensus; more than 25,000 new MCV customers; management expects to exceed its 2023–2026 OPAT-per-share CAGR target.
- Weaknesses
- Quarterly growth can be affected by one-offs.
- Comparison
- Only AIA China and CPIC achieved positive 2Q growth among the discussed life insurers.
- Risks
- Sustainability of MCV demand and quarterly growth volatility.
- FWD Group Holdings Ltd (1828.HK)Regional life-insurance peer with broad-based growth.
- Strengths
- Management expects full-year 2026 NB CSM and VNB margins to improve versus 2025.
- Weaknesses
- Margins are expected to moderate in 2H versus 1H due to seasonality, especially in Hong Kong.
- Comparison
- MCV represented about 24% of Hong Kong business in 1H26, lower than key peers.
- Risks
- Seasonal margin moderation and execution in expansion markets.
- Ping An Insurance Group Co of China Ltd (2318.HK, 601318.SS)China insurance peer with stronger bancassurance growth and AI-led operating initiatives.
- Strengths
- Management expects multi-channel distribution, enhanced services and AI enablement to support VNB growth over time.
- Weaknesses
- VNB margin did not increase, unlike most peers.
- Comparison
- Reported stronger banca growth while most peers relied more on agency.
- Risks
- New bancassurance regulation and temporary pressure on net investment yield.
- China Life Insurance Co Ltd (2628.HK, 601628.SS)China life-insurance peer with improving ALM indicators.
- Strengths
- Duration gap narrowed below 1.3 years and new-business guaranteed liability cost fell to 1.73% in 1H26.
- Weaknesses
- Bancassurance has been in an adjustment period since July.
- Comparison
- Reported strong earnings and VNB momentum, with DPS up 50%.
- Risks
- Adjustment to granular bancassurance-expense regulation.
- China Pacific Insurance Group Co Ltd (2601.HK, 601601.SS)China life and P&C insurance peer.
- Strengths
- One of the few insurers with better 2Q than 1Q performance; management sees channel-expansion opportunities.
- Comparison
- Along with AIA China, it was among the only insurers with positive 2Q growth.
- Risks
- Execution of agency and bancassurance expansion.
- PICC Group (1339.HK, 601319.SS) / PICC P&C Company Ltd (2328.HK)China insurance and P&C peer.
- Strengths
- Robust P&C performance; PICC P&C reported a 94.0% combined ratio.
- Weaknesses
- PICC Group’s VNB was described as soft.
- Comparison
- P&C profitability was among the sector’s strongest.
- Risks
- Life new-business softness and catastrophe-loss pressure.
- China Taiping Insurance Holdings Co Ltd (0966.HK)China insurance peer.
- Strengths
- 1H26 earnings rose 90%; management sees further reductions in VNB interest-rate sensitivity.
- Weaknesses
- Weaker VNB and combined-ratio trends.
- Comparison
- Unlike most peers, it posted single-digit VNB growth.
- Risks
- Higher catastrophe losses and weaker life-insurance growth.
- ZhongAn Online P & C Insurance Co Ltd (6060.HK)Online P&C insurance peer.
- Strengths
- Earnings increased 1.3x, combined ratio was 95.5%, and AI is integrated across operations.
- Weaknesses
- Consumer-finance premium is expected to continue contracting.
- Comparison
- Auto premium is expected to accelerate in 2H26 while the health ecosystem is expected to grow double digit in 2027.
- Risks
- Consumer-finance contraction.
- New China Life Insurance Company Ltd (1336.HK, 601336.SS)China life-insurance peer.
- Strengths
- Earnings rose 54%; the company added high-dividend equities and has upgraded the strategic position of bancassurance.
- Weaknesses
- VNB and DPS were below Morgan Stanley’s estimates.
- Comparison
- Management sees multiple ALM-rule metrics and constraints still requiring improvement.
- Risks
- ALM-rule compliance and execution.
Key data
- 1H26 earnings growthDouble-digit for all insurersSupported by the equity rally.
- China insurers annualized operating ROE14–21%May decline slightly but remained healthy.
- 1H26 VNB growth11–34%Except PICC Life and Taiping at single-digit growth.
- Net investment yield1.2–1.5%Down 0.1–0.4ppt across peers.
- Gross investment yield2.1–4.2%Rose to a strong level in 1H26.
- China Life effective duration gapBelow 1.3 yearsNarrowed in 1H26.
- PICC P&C combined ratio94.0%Reported as exceptional in 1H26.
- ZhongAn combined ratio95.5%Reported alongside earnings growth of 1.3x.
Impact & implications
The report argues that insurers’ 1H26 performance reflects resilient operating execution, improved P&C profitability and healthier life-insurance fundamentals. Near-term reported growth may slow because of high bases, catastrophe exposure and bancassurance regulation, making channel adaptation and sales momentum the key determinants of the next phase.
Risks
- Tough 3Q26 earnings and VNB comparisons could pressure reported growth.
- Strengthened bancassurance regulation could weigh on near-term sales growth while insurers adjust.
- Higher 3Q catastrophe losses may create short-term P&C profitability pressure.
- Net investment yields remain under pressure and require monitoring under new ALM rules.
What to watch
- Sales momentum after the late-August high base.
- How the bancassurance channel adapts to strengthened regulation.
- The start and execution of 2027 sales preparation.
- The sustainability of growth momentum and 3Q26 earnings and VNB comparisons.